Pathology and genetics of meningiomas
Related Experiment Video
Updated: May 26, 2026

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
Hussein Alahmadi1, Sidney E Croul
1Department of Surgery, Division of Neurosurgery, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada.
Abstract:
This article constitutes a mini-review of the pathology and genetics of meningiomas. Meningiomas are the most common primary intracranial tumors. They are usually durally based and are often found adjacent to venous sinuses and dural infoldings. The majority of these tumors are WHO grade I, although a minority is WHO grade II, atypical, or WHO grade III, anaplastic. Grade II and III meningiomas show a greater tendency than Grade I tumors to recur and metastasize. The current WHO scheme recognizes 15 histologic subtypes of meningiomas. Nine of these are WHO grade I, three are grade II, and three are grade III. In addition to these histologic subtypes, meningiomas can also be graded on the basis of mitotic activity, evidence of brain invasion, growth pattern cellular density, nuclear atypia, and necrosis. Loss of the long arm of chromosome 22, which is usually associated with inactivation of the NF2 gene, is the most common genetic abnormality found in meningiomas. Other chromosomal abnormalities associated with tumorogenesis and increased gradeof meningiomas include loss of heterozygosity for chromosome 1p, loss of 14q, deletion of 9p21, abnormalities of chromosome 10 and 17q. Telomerase activity increases with meningiomas grade as well. The only proven environmental risk factor for meningiomas is ionizing radiation. Radiation-induced meningiomas are more often multiple and have higher recurrence rates than standard meningiomas.
Insights
Meningiomas, common brain tumors, are classified by WHO grades. Genetic changes like chromosome 22 loss and radiation exposure influence their development and recurrence risk.
Area of Science:
- Neuro-oncology
- Tumor Pathology
- Cancer Genetics
Background:
- Meningiomas are the most common primary intracranial tumors, typically dural-based.
- They are classified into WHO grades I, II, and III, with higher grades indicating increased recurrence and metastasis.
- Fifteen histologic subtypes exist, further categorized by specific grading criteria.
Purpose of the Study:
- To provide a mini-review of meningioma pathology and genetics.
- To summarize current understanding of meningioma classification and risk factors.
Main Methods:
- Review of existing literature on meningioma pathology and genetics.
- Analysis of WHO classification system for meningiomas.
- Summary of genetic abnormalities and environmental risk factors.
Main Results:
- Loss of chromosome 22 (NF2 gene inactivation) is the most frequent genetic abnormality.
- Other genetic factors include chromosomal losses at 1p, 14q, 9p21, and abnormalities of chromosomes 10 and 17q.
- Ionizing radiation is the sole established environmental risk factor, linked to multiple tumors and higher recurrence rates.
Conclusions:
- Meningioma grade, histology, genetics, and environmental factors are crucial for understanding tumor behavior.
- Further research into genetic drivers and risk factors can inform diagnosis and treatment strategies.
